FRIDAY, April 5, 2024 (HealthDay News) — Obese folks are less likely to benefit from a nerve-stimulation treatment for sleep apnea that’s recently been made available to them, a new study reports. The treatment is likely to be 75% less effective among obese people with BMIs of 32 to 35,Continue Reading
THURSDAY, April 4, 2024 (HealthDay News) — Two newly discovered genetic variations can have a powerful effect on a person’s risk for obesity, a new report says. Variants in the gene BSN, also known as Bassoon, can increase risk of obesity as much as sixfold, researchers report April 4 inContinue Reading
THURSDAY, April 4, 2024 (HealthDay News) — There’s a glimmer of hope for people afflicted by a rare artery-hardening disease than can lead to amputation. An existing medication called etidronate appears to help slow the buildup of calcium in arteries that’s a hallmark of the illness, which is called arterialContinue Reading
WEDNESDAY, April 3, 2024 (HealthDay News) — Research into germs that travel through the human digestive tract shows that some may promote obesity while others might help prevent it. Not only that, but those microbes may act differently in men versus women, the same study found. “Our findings reveal howContinue Reading
TUESDAY, April 2, 2024 (HealthDay News) — The seeds of high blood pressure in adulthood might be sown in youth, a new study suggests. Children and teenagers with excess weight were more likely to have high blood pressure in middle age, researchers report. In fact, there’s a linear relationship betweenContinue Reading
FRIDAY, March 29, 2024 (HealthDay News) — People taking weight-loss drugs like Ozempic and Wegovy need to drop them in the days or weeks prior to surgery, a new study warns. Folks on one of these drugs — known as GLP-1 receptor agonists — have a 33% higher risk ofContinue Reading
FRIDAY, March 29, 2024 (HealthDay News) — Children who are obese face double the odds of developing multiple sclerosis later in life, a new study warns. The overall odds for any one child to develop the neurodegenerative illness remains very low. However, the Swedish researchers believe the link could helpContinue Reading
WEDNESDAY, March 27, 2024 (HealthDay News) — Some folks struggling with obesity appear to be hampered by their own genes when it comes to working off those extra pounds, a new study finds. People with a higher genetic risk of obesity have to exercise more to avoid becoming unhealthily heavy,Continue Reading
FRIDAY, March 22, 2024 (HealthDay News) — Medicare will now cover the popular weight-loss drug Wegovy if patients using it also have heart disease, U.S. officials announced Thursday. The move comes after the U.S. Food and Drug Administration approved drugmaker Novo Nordisk’s application to add cardiovascular benefits to the medicine’s label earlierContinue Reading
WEDNESDAY, March 20, 2024 — Boys who drink lots of sugary soda and fruit juice could be more likely to develop type 2 diabetes later in life, a new study has found. Each daily 8-ounce serving of sugary drinks during a boy’s childhood is associated with a 34% increase inContinue Reading
TUESDAY, March 19, 2024 (HealthDay News) — Intermittent fasting might be bad for your heart, a new study warns. People who restricted their eating to an 8-hour window had nearly twice the risk of heart-related death compared to folks who ate freely, results show. This runs counter to previous researchContinue Reading
THURSDAY, March 14, 2024 (HealthDay News) — The blockbuster weight-loss medication Zepbound (tirzepatide) appears to help folks quickly shed pounds regardless of how overweight they are, or how long they’ve lived being overweight or obese. Those are the findings of two separate analyses of a major trial of the injectedContinue Reading
WEDNESDAY, March 13, 2024 (HealthDay News) — Nurses who specialize in anesthesia have issued new guidelines to reduce the risk that patients taking weight-loss drugs like Ozempic or Wegovy throw up during surgery. “These medications have exploded in popularity,” said Micah Walden, of the American Association of Nurse Anesthesiology (AANA) PracticeContinue Reading
FRIDAY, March 8, 2024 (HealthDay News) — Wegovy (semaglutide), the weight-loss version of blockbuster diabetes drug Ozempic, was approved on Friday by the U.S. Food and Drug Administration to help prevent heart attack, stroke and heart death. “Wegovy is now the first weight-loss medication to also be approved to helpContinue Reading